BeyondSpring Inc. Proceeds from Common Stock Issued
BeyondSpring Inc. (BYSI) reported Proceeds from Common Stock Issued of $2.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2026-03-25
- BeyondSpring Inc. proceeds from issuance of common stock for the quarter ending 2025-12-31 was $2.00M.
- BeyondSpring Inc. proceeds from issuance of common stock for the quarter ending 2025-09-30 was $0.00.
- BeyondSpring Inc. proceeds from issuance of common stock for the quarter ending 2024-12-31 was $0.00.
- BeyondSpring Inc. proceeds from issuance of common stock for the quarter ending 2024-09-30 was $0.00.
- BeyondSpring Inc. proceeds from issuance of common stock for fiscal 2025 was $2.00M, a 33.33% decline from fiscal 2024.
- BeyondSpring Inc. proceeds from issuance of common stock for fiscal 2024 was $3.00M.
- BeyondSpring Inc. proceeds from issuance of common stock for fiscal 2023 was $0.00.
| Period end | Proceeds from Issuance of Common Stock 2 month | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 8 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month | Proceeds from Issuance of Common Stock 20 month |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $2.00M derived: sum of 2 quarters · filed 2026-03-25 | $2.00M 10-K · filed 2026-03-25 | ||||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $0.00 10-Q · filed 2025-11-12 | |||||
| 2025-06-30 | $0.00 10-Q · filed 2025-08-13 | ||||||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $0.00 derived: sum of 2 quarters · filed 2026-03-25 | $3.00M 10-K · filed 2026-03-25 | ||||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $3.00M 10-Q · filed 2025-11-12 | |||||
| 2024-06-30 | $3.00M 10-Q · filed 2025-08-13 | ||||||
| 2023-12-31 | $0.00 10-K · filed 2025-03-27 | ||||||
| 2022-12-31 | $0.00 20-F · filed 2023-04-18 | ||||||
| 2021-12-31 | $0.00 derived: 20-F 12 month − 6-K 9 month · filed 2023-04-18 | $0.00 derived: sum of 2 quarters · filed 2023-04-18 | $82.00K derived: sum of 3 quarters · filed 2023-04-18 | $0.00 20-F · filed 2023-04-18 | |||
| 2021-09-30 | $0.00 derived: 6-K 9 month − 6-K 6 month · filed 2021-12-30 | $82.00K derived: sum of 2 quarters · filed 2021-12-30 | $0.00 6-K · filed 2021-12-30 | $80.64M derived: sum of 4 quarters · filed 2023-04-18 | |||
| 2021-06-30 | $82.00K derived: 6-K 6 month − 6-K 3 month · filed 2021-09-10 | $0.00 6-K · filed 2021-09-10 | $80.64M derived: sum of 3 quarters · filed 2023-04-18 | $85.64M derived: sum of 4 quarters · filed 2023-04-18 | |||
| 2021-03-31 | -$82.00K 6-K · filed 2021-06-16 | $80.56M derived: sum of 2 quarters · filed 2023-04-18 | $85.56M derived: sum of 3 quarters · filed 2023-04-18 | ||||
| 2020-12-31 | $80.64M derived: 20-F 12 month − 6-K 9 month · filed 2023-04-18 | $85.64M derived: sum of 2 quarters · filed 2023-04-18 | $112.58M 20-F · filed 2023-04-18 | ||||
| 2020-09-30 | $5.00M derived: 6-K 9 month − 6-K 6 month · filed 2021-12-30 | $31.93M 6-K · filed 2021-12-30 | |||||
| 2020-06-30 | $26.94M 6-K · filed 2021-09-10 | ||||||
| 2019-12-31 | $24.50M derived: 20-F 12 month − 6-K 9 month · filed 2022-04-14 | $63.86M derived: sum of 2 quarters · filed 2022-04-14 | $69.45M 20-F · filed 2022-04-14 | $14.00M 20-F · filed 2020-04-30 | |||
| 2019-11-30 | $25.77M 6-K · filed 2019-12-18 | ||||||
| 2019-09-30 | $39.36M derived: 6-K 9 month − 6-K 6 month · filed 2020-11-17 | $44.96M 6-K · filed 2020-11-17 | |||||
| 2019-06-30 | $5.60M 6-K · filed 2020-09-03 | ||||||
| 2018-12-31 | $0.00 derived: 20-F 12 month − 6-K 9 month · filed 2021-04-30 | $0.00 derived: sum of 2 quarters · filed 2021-04-30 | $14.00M 20-F · filed 2019-04-30 | $14.00M 20-F · filed 2021-04-30 | |||
| 2018-09-30 | $0.00 derived: 6-K 9 month − 6-K 6 month · filed 2019-12-18 | $14.00M 6-K · filed 2019-12-18 | |||||
| 2018-06-30 | $14.00M 6-K · filed 2018-10-23 | $14.00M 6-K · filed 2019-09-18 | |||||
| 2017-12-31 | $0.00 derived: 20-F 12 month − 6-K 9 month · filed 2020-04-30 | $0.00 derived: sum of 2 quarters · filed 2020-04-30 | $0.00 derived: sum of 3 quarters · filed 2020-04-30 | $50.51M 20-F · filed 2020-04-30 | |||
| 2017-09-30 | $0.00 derived: 6-K 9 month − 6-K 6 month · filed 2017-11-09 | $0.00 derived: sum of 2 quarters · filed 2018-10-23 | $50.51M 6-K · filed 2017-11-09 | $50.51M derived: sum of 4 quarters · filed 2019-04-30 | |||
| 2017-06-30 | $0.00 derived: 6-K 6 month − 6-K 3 month · filed 2018-10-23 | $50.51M 6-K · filed 2018-10-23 | $50.51M derived: sum of 3 quarters · filed 2019-04-30 | ||||
| 2017-03-31 | $50.51M 6-K · filed 2018-06-21 | $50.51M derived: sum of 2 quarters · filed 2019-04-30 | |||||
| 2016-12-31 | $0.00 derived: 20-F 12 month − 6-K 9 month · filed 2019-04-30 | $15.25M 20-F · filed 2019-04-30 | |||||
| 2016-09-30 | $15.25M 6-K · filed 2017-11-09 | ||||||
| 2015-12-31 | $16.00M 20-F · filed 2018-04-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |